title: Autologous transplantation therapy for chronic myelogenous leukemia.
authors.affiliation: Department of Medicine, University of Minnesota, Minneapolis 55455, USA.
authors.forename: R
authors.initials: R
authors.lastname: Bhatia
authors.forename: C M
authors.initials: CM
authors.lastname: Verfaillie
authors.forename: J S
authors.initials: JS
authors.lastname: Miller
authors.forename: P B
authors.initials: PB
authors.lastname: McGlave
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D012008:Recurrence; D016019:Survival Analysis
chemical_list: D004791:Enzyme Inhibitors; D007155:Immunologic Factors; D016898:Interferon-alpha; D016376:Oligonucleotides, Antisense; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl